Moriarty John B
Insider CIK 1564621 · PTLA EVP, General Counsel · MRTX Chief Legal Officer · RNA Chief Legal Officer · OLMA EVP, Ch. Legal Officer & Sec. · KARD Chief Legal Officer · ALXN SVP & General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KARD Kardigan, Inc. | A Award | 2026-06-17 | 2026-06-22 | 47,784 | — | $0 | 47,784 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 50,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 160,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer | 2026-02-27 | 2026-02-27 | 92,054 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2026-01-07 | 2026-01-09 | 2,374 | $72.23 | $171.5K | 74,557 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2025-12-17 | 2025-12-19 | 56,000 | — | $0 | 103,755 | SEC↗ |
| RNA Avidity Biosciences, Inc. | F Tax w/h | 2025-12-17 | 2025-12-19 | 26,824 | $71.87 | $1.93M | 76,931 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-04 | 2025-08-05 | 2,245 | $36.21 | $81.3K | 47,755 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2025-01-06 | 2025-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2025-01-06 | 2025-01-08 | 25,000 | — | $0 | 50,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2024-08-01 | 2024-08-05 | 160,000 | — | $0 | 160,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2024-08-01 | 2024-08-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 83,525 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 71,660 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 675 | — | $0 | 71,660 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-08-09 | 2023-08-10 | 22,297 | $37.00 | $825.0K | 71,660 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2023-02-01 | 2023-02-02 | 150,000 | — | $0 | 150,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2022-02-01 | 2022-02-03 | 166,250 | — | $0 | 166,250 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2020-11-18 | 2020-11-19 | 161,406 | — | $0 | 161,406 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2020-09-19 | 2020-11-19 | 252,060 | — | $0 | 252,060 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 65,000 | $5.21 | $338.6K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 48,750 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 96,874 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 32,500 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 37,083 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 24,375 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer | 2020-07-02 | 2020-07-02 | 12,893 | $18.00 | $232.1K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2020-03-02 | 2020-03-03 | 4,327 | $9.68 | $41.9K | 49,976 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2020-02-24 | 2020-02-26 | 73,125 | — | $0 | 73,125 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2020-02-03 | 2020-02-04 | 3,544 | $12.89 | $45.7K | 53,184 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2020-01-31 | 2020-02-04 | 65,000 | — | $0 | 65,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2020-01-31 | 2020-02-04 | 16,250 | — | $0 | 56,728 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2019-03-04 | 2019-03-05 | 4,297 | $33.42 | $143.6K | 39,952 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2019-01-31 | 2019-02-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2019-01-31 | 2019-02-04 | 18,750 | — | $0 | 43,750 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2018-03-29 | 2018-03-30 | 125,000 | — | $0 | 125,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2018-03-29 | 2018-03-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2018-02-08 | 2018-02-08 | 2,163 | $115.70 | $250.3K | 75,737 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2018-02-08 | 2018-02-08 | 1,200 | $115.70 | $138.8K | 74,537 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2018-02-06 | 2018-02-08 | 6,500 | — | $0 | 77,900 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2018-02-06 | 2018-02-08 | 21,489 | — | $0 | 71,400 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2018-02-05 | 2018-02-07 | 1,261 | $117.26 | $147.9K | 49,911 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-03-01 | 2017-03-01 | 282 | $132.50 | $37.4K | 44,672 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2017-02-28 | 2017-03-01 | 12,800 | — | $0 | 12,800 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2017-02-28 | 2017-03-01 | 6,500 | — | $0 | 51,172 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-02-28 | 2017-03-01 | 910 | $131.71 | $119.9K | 44,954 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-02-27 | 2017-03-01 | 612 | $131.20 | $80.3K | 45,864 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-02-09 | 2017-02-10 | 167 | $126.84 | $21.2K | 46,476 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-02-07 | 2017-02-08 | 135 | $128.09 | $17.3K | 46,643 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-02-06 | 2017-02-08 | 3,380 | $125.69 | $424.8K | 46,801 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-02-06 | 2017-02-08 | 23 | $126.38 | $2.9K | 46,778 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-12-12 | 2016-12-13 | 1,044 | $118.61 | $123.8K | 50,181 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-08-08 | 2016-08-10 | 135 | $137.14 | $18.5K | 51,225 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-06-13 | 2016-06-14 | 918 | $135.72 | $124.6K | 51,360 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-29 | 2016-03-01 | 1 | $140.65 | $141 | 52,278 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-29 | 2016-03-01 | 1,200 | $138.91 | $166.7K | 52,279 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2016-02-26 | 2016-03-01 | 31,000 | $140.16 | $4.34M | 31,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2016-02-26 | 2016-03-01 | 5,000 | — | $0 | 53,479 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-08 | 2016-02-08 | 137 | $138.02 | $18.9K | 50,997 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-08 | 2016-02-08 | 2,418 | $138.02 | $333.7K | 48,501 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-08 | 2016-02-08 | 78 | $140.21 | $10.9K | 50,919 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 400 | $144.39 | $57.8K | 52,203 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 500 | $145.27 | $72.6K | 52,603 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 433 | $141.75 | $61.4K | 51,134 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 436 | $142.18 | $62.0K | 51,567 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 200 | $143.44 | $28.7K | 52,003 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2016-02-04 | 2016-02-08 | 11,763 | — | $0 | 53,103 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-12-11 | 2015-12-15 | 918 | $182.65 | $167.7K | 41,365 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-12-11 | 2015-12-15 | 25 | $185.54 | $4.6K | 41,340 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-08-07 | 2015-08-11 | 135 | $190.01 | $25.7K | 42,283 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2015-08-05 | 2015-08-05 | 10,000 | $92.65 | $926.5K | 45,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-08-05 | 2015-08-05 | 6,574 | $198.12 | $1.30M | 35,854 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2015-08-05 | 2015-08-05 | 10,000 | $92.65 | $926.5K | 42,428 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-08-05 | 2015-08-05 | 3,436 | $199.05 | $683.9K | 32,418 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2015-08-05 | 2015-08-05 | 10,000 | $92.65 | $926.5K | 42,418 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-06-11 | 2015-06-12 | 914 | $170.00 | $155.4K | 32,428 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-03-02 | 2015-03-03 | 280 | $180.34 | $50.5K | 33,342 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2015-02-27 | 2015-03-03 | 5,874 | — | $0 | 5,874 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2015-02-27 | 2015-03-03 | 24,400 | — | $0 | 24,400 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2015-02-27 | 2015-03-03 | 1,745 | — | $0 | 33,622 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2015-02-27 | 2015-03-03 | 5,100 | — | $0 | 31,877 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-02-10 | 2015-02-12 | 1,490 | $171.15 | $255.0K | 26,777 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-02-09 | 2015-02-09 | 1,455 | $174.16 | $253.4K | 28,267 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2015-02-05 | 2015-02-09 | 8,760 | — | $0 | 29,722 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-12-11 | 2014-12-15 | 3,570 | $195.53 | $698.0K | 20,962 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-10-27 | 2014-10-28 | 10,000 | $92.65 | $926.5K | 12,812 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-10-27 | 2014-10-28 | 73 | $190.00 | $13.9K | 24,532 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-10-27 | 2014-10-28 | 10,000 | $92.65 | $926.5K | 34,532 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-10-27 | 2014-10-28 | 9,927 | $189.49 | $1.88M | 24,605 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-10-06 | 2014-10-08 | 10,000 | $92.65 | $926.5K | 22,812 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-10-06 | 2014-10-08 | 10,000 | $95.65 | $956.5K | 34,532 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-10-06 | 2014-10-08 | 10,000 | $179.00 | $1.79M | 24,532 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-10-06 | 2014-10-28 | 10,000 | $92.65 | $926.5K | 24,532 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2014-02-28 | 2014-03-04 | 36,900 | $176.80 | $6.52M | 36,900 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2014-02-28 | 2014-03-04 | 2,300 | — | $0 | 24,532 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-07 | 2014-02-10 | 16 | $158.56 | $2.5K | 22,232 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-07 | 2014-02-10 | 1,020 | $155.55 | $158.7K | 22,248 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2014-02-06 | 2014-02-10 | 6,068 | — | $0 | 23,268 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2013-02-06 | 2013-02-08 | 29,600 | — | $0 | 29,600 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2013-02-06 | 2013-02-08 | 2,200 | — | $0 | 17,200 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-12-10 | 2012-12-18 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-12-10 | 2012-12-18 | 15,000 | — | $0 | 15,000 | SEC↗ |